6 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
PROMOTING MENTAL WELLBEING IN THE AGEING URBAN POPULATION: DETERMINANTS, POLICIES AND INTERVENTIONS IN EUROPEAN CITIES (MINDMAP)
Date du début: 1 janv. 2016, Date de fin: 31 déc. 2019,
Major depressive disorder, dementia, anxiety disorders, and substance abuse affect a substantial part of the European older population. Over 70% of Europeans reside in cities, and this percentage will increase in the next decades. Urbanization and ageing have enormous implications for public mental health. Cities pose major challenges for older citizens, but also offer opportunities for the design ...
Voir le projet
14
Participants partenaires
TERMINÉ
Trans Channel Neuroscience Network (TC2N)
Date du début: 31 août 2009, Date de fin: 29 juin 2014,
The TC2N project is managed by a federation of 40 laboratories from Nijmegen to Brest, via Portsmouth called the LARC-Neuroscience Network. The project will focus on 5 main research topics: cerebrovascular accident (CVA), eating disorders, tumors, neurodevelopmental diseases and (neuro)endocrine disruptives.The main objectives of the project are: - to boost, widen and develop the LARC-Neuroscience ...
Voir le projet
11
Participants partenaires
TERMINÉ
Arrhythmogenic potential of drugs (ARITMO)
Date du début: 1 janv. 2010, Date de fin: 30 juin 2013,
The ability of some compounds to prolong the QT interval of the electrocardiogram and to precipitate Torsade de Pointes (TdP, a potentially fatal arrhythmia) has caused several regulatory interventions, including drug withdrawals. Specific guidelines have been implemented to detect QT liability of new compounds as early as possible. However there is growing evidence that an increase in the QT inte ...
Voir le projet
21
Participants partenaires
TERMINÉ
A pharmacogenomic approach to coumarin anticoagulant therapy (EU-PACT)
Date du début: 1 oct. 2008, Date de fin: 31 mars 2013,
"The effectiveness of treatment with oral anticoagulants in the prevention of thrombotic disorders is well established, but these drugs are potentially dangerous because of their narrow therapeutic index. In Europe three coumarins are used: warfarin, acenocoumarol, and phenprocoumon. Genetic factors that have been recently demonstrated to change the pharmacokinetics and pharmacodynamics of coumari ...
Voir le projet
12
Participants partenaires
TERMINÉ
Safety Of non-Steroidal anti-inflammatory drugs (SOS)
Date du début: 1 nov. 2008, Date de fin: 30 avr. 2012,
"The Safety Of non-Steroidal anti-inflammatory drugs (SOS) proposal aims to assess the relative cardiovascular (CVD) and gastrointestinal (GI) safety of non-steroidal anti-inflammatory drugs (NSAIDs). The NSAIDs are divided in traditional NSAIDs (tNSAIDs) and the newer COX-II inhibitors(coxibs). The aim will be fulfilled by a two-phase approach comprising systematic reviews and synthesis of CVD an ...
Voir le projet
11
Participants partenaires
TERMINÉ
Monk seal & fisheries: Mitigating the conflict in Greek seas (MOFI)
Date du début: 1 juil. 2005, Date de fin: 30 juin 2009,
Background
The Monk seal (Monachus monachus) is one of the six most threatened mammals in the world. In 1993, the Greek population was estimated at 200-250 individuals. This is the largest global population and it represents 90% of the European population. In Greece, 15 years of efforts to conserve the monk seal have led to the establishment of a strictly ...
Voir le projet